In the 82-IPMN subcohort, GNAS mutations yielded the highest sensitivity (70%) and perfect specificity (100%) among mucinous criteria (Figure 4, Supplementary Table S6, http://links.lww.com/CTG/B338). This evidence concerns the gene GNAS and pancreatic intraductal papillary-mucinous neoplasm.